Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sickle cell disease; a general overview.

J B Schnog1, A J Duits, F A J Muskiet

  • 1Department of Internal Medicine, St Elisabeth Hospital, Curaçao, the Netherlands Antilles. jschnog@wanadoo.nl

The Netherlands Journal of Medicine
|February 3, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Keynote-177 Randomized Controlled Trial of First-line PD-1 Blockade for Microsatellite-High or Mismatch Repair-Deficient Advanced Colorectal Cancer: Potential Consequences of the Cross-Over Trial Design and Related Issues.

Cancer medicine·2026
Same author

Healthcare professionals' perspectives on prescribing DOACs to frail older patients; the DOAC-FRAIL questionnaire.

BMC geriatrics·2026
Same author

Predicting clinically relevant bleeding in new-onset atrial fibrillation patients initiating oral anticoagulant therapy: External validation of the AF-BLEED score.

Thrombosis research·2025
Same author

Characteristics of professional society oncological drug evaluation in the Netherlands from 2016 to 2020: A retrospective analysis.

Journal of cancer policy·2025
Same author

Design issues with lutetium-177 PSMA-617 registration studies that bias the outcome of the experimental arm reflect an increasing misalignment of contemporary oncology trials with true patient benefit.

BJC reports·2024
Same author

Pharmaceutical Industry Payments to Medical Oncologists in the Netherlands: Trends and Patterns Provided by an Open-Access Transparency Data Set.

JCO oncology practice·2024
Same journal

A diagnostic tool for self-poisoned patients: Analysis of gastric content and lavage fluids.

The Netherlands journal of medicine·2020
Same journal

Answer to Photoquiz A bone disorder with skin lesions.

The Netherlands journal of medicine·2020
Same journal

A bone disorder with skin lesions.

The Netherlands journal of medicine·2020
Same journal

Answer to Photoquiz A fascinating liver abscess.

The Netherlands journal of medicine·2020
Same journal

A fascinating liver abscess.

The Netherlands journal of medicine·2020
Same journal

Answer to Photoquiz A polyposis syndrome.

The Netherlands journal of medicine·2020
See all related articles

Sickle cell disease (SCD) is a complex blood disorder with serious health issues. Understanding its causes and symptoms is crucial for doctors, especially as SCD becomes more common.

Area of Science:

  • Hematology
  • Genetics
  • Internal Medicine

Background:

  • Sickle cell disease (SCD) is a complex genetic blood disorder.
  • It causes chronic hemolysis, infection susceptibility, and vaso-occlusive crises.
  • SCD significantly impacts patient quality of life and life expectancy.

Purpose of the Study:

  • To highlight the importance of understanding SCD pathophysiology and clinical syndromes.
  • To inform medical practitioners in the Netherlands about the increasing prevalence of SCD.
  • To emphasize the need for comprehensive knowledge among local healthcare providers.

Main Methods:

  • This study is a review of existing literature on sickle cell disease.
  • It synthesizes information on the pathophysiology, clinical manifestations, and current treatments.

Related Experiment Videos

  • Focuses on the implications for medical practice in the Netherlands.
  • Main Results:

    • SCD presents with diverse and severe complications, including organ damage.
    • Effective treatments are limited to hydroxyurea, transfusions, and bone marrow transplant.
    • The prevalence of SCD is increasing in the Netherlands.

    Conclusions:

    • A thorough understanding of SCD is essential for Dutch medical practitioners.
    • Early recognition and management of SCD complications are critical.
    • Further research and awareness are needed to address the growing burden of SCD.